rosiglitazone has been researched along with n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marathe, GK; McIntyre, TM; Pontsler, AV; St Hilaire, A; Zimmerman, GA | 1 |
| Chen, GS; Ding, GX; Luo, C; Ou, XL; Shao, Y; Sun, WH; Xiao, B; Xu, HC; Xue, YP; Yang, Y; Zhang, Y; Zhao, QS; Zhou, SM | 1 |
| Carluccio, MA; De Caterina, R; Distante, A; Massaro, M; Scoditti, E; Storelli, C | 1 |
3 other study(ies) available for rosiglitazone and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
| Article | Year |
|---|---|
Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein.
Topics: Base Sequence; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; DNA Primers; Enzyme Induction; Humans; Immunohistochemistry; Isoenzymes; Lipoproteins, LDL; Membrane Proteins; Monocytes; Nitrobenzenes; Oxidation-Reduction; Phospholipids; Prostaglandin-Endoperoxide Synthases; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sulfonamides; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |
Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells.
Topics: Apoptosis; Base Sequence; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase Inhibitors; DNA Primers; Electrophoresis, Polyacrylamide Gel; Humans; Immunohistochemistry; Nitrobenzenes; Pancreatic Neoplasms; PPAR gamma; Proliferating Cell Nuclear Antigen; Rosiglitazone; Sulfonamides; Thiazolidinediones | 2009 |
PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
Topics: Angiogenesis Inhibitors; Anilides; Benzhydryl Compounds; Benzophenones; Binding Sites; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Down-Regulation; Endothelial Cells; Epoxy Compounds; Gene Expression Regulation, Enzymologic; Humans; Neovascularization, Physiologic; Nitrobenzenes; PPAR gamma; Promoter Regions, Genetic; Protein Kinase C-alpha; Protein Transport; RNA Interference; RNA, Messenger; Rosiglitazone; Sulfonamides; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transfection; Tyrosine; Vascular Endothelial Growth Factor A | 2010 |